Coeptis (COEP) Extinguishes Convertible Note with YA II PN, Ltd
WEXFORD, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Coeptis Therapeutics Holdings, Inc. (Nasdaq: COEP) (“Coeptis” or the “Company”), a next-gen...
Month: July 2025
Polyrizon Reports Successful Intranasal Delivery of PL-14 Allergy Blocker in Latest Study
Ra’anana, Israel, July 22, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing...
Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025
BRISBANE, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical...
Veru to Participate in the 2025 BTIG Virtual Biotech Conference
MIAMI, FL, July 22, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call
MALVERN, Pa., July 22, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...
InStride Health Strengthens Executive Team with Appointment of Chief Commercial Officer and Chief Financial Officer
Veteran consumer and healthcare leaders will support InStride’s mission to scale evidence-based pediatric mental health careBOSTON, July 22, 2025 (GLOBE...
Autonomix Medical, Inc. Exercise of Warrants for $2.5 Million Gross Proceeds
THE WOODLANDS, TX, July 22, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device...
Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales
Company Continues to Strengthen Organizational Infrastructure with Success-Driven Medical Device Veteran Christina Bailey, VP of Sales, Microbot Medical Microbot Medical®...
SeaStar Medical Reports Positive Results for QUELIMMUNE Therapy in Pediatric Acute Kidney Injury (AKI) from the First 20 SAVE Surveillance Registry Patients
DENVER, July 22, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today positive...
Full Alliance Group and Qubitera Holdings Launch Informational Website for YAHBEE – the First Three Tier Affiliate Cross Chain Wallet built for the GIG Economy
TAMPA, Fla., July 22, 2025 (GLOBE NEWSWIRE) -- Full Alliance Group, Inc. (OTC: FAGI) (“the Company”), today announced that its...
NKGen Biotech to Present at the Alzheimer’s Association International Conference 2025
SANTA ANA, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (OTC: NKGN) (“NKGen” or the “Company”), a clinical-stage...
Catalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
The Company will Host a Conference Call and Webcast on Thursday, August 7, 2025, at 8:30 AM ETCORAL GABLES, Fla.,...
Dr Oliver Sartor Appointed to Radiopharm Scientific Advisory Board
SYDNEY, July 22, 2025 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX:RAD, “Radiopharm” or the “Company”), a clinical-stage biopharmaceutical company focused on...
BioVie Appoints Industry Veterans Amy Chappell, MD, FAAN, and Kameel Farag to Board of Directors
Seasoned leaders bring deep expertise in neuroscience drug development, strategic growth, and corporate finance to support BioVie’s missionCARSON CITY, Nev.,...
Join Calidi Biotherapeutics’ Exclusive Live Investor Webinar and Q&A Session on July 24
SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (“Calidi” or the “Company”) (NYSE American: CLDI), a clinical-stage...
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
Proceeds to primarily support MASH pipeline expansion and to refinance existing senior credit facility$350 million initial term loan funded at...
AnswersNow Launches Corporate Advisory Board to Advance Scale of Innovative Virtual Autism Platform
Board brings together diverse industry veterans representing insurers, educators, clinicians and healthcare providers to ensure a robust, practical approach to...
Sutro Biopharma Announces Research Collaboration with the FDA to Advance Regulatory Standards for Antibody Drug Conjugates
SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an...
aTyr Pharma Announces Last Patient Visit in Phase 3 EFZO-FIT™ Study of Efzofitimod in Patients with Pulmonary Sarcoidosis
Topline results expected in the third quarter of 2025.SAN DIEGO, July 22, 2025 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq:...
Health care advocates afraid of major cuts and privatization hold rally at Council of the Federation
HUNTSVILLE, Ontario, July 22, 2025 (GLOBE NEWSWIRE) -- Outside the Council of the Federation and the gathering of First Ministers,...